aidsmap HIV & AIDS news

HIV/HCV coinfected
people who delay hepatitis C treatment remain at risk for liver failure,
hepatocellular carcinoma and liver-related death even after being cured -- with
outcomes worsening the longer it is put off ...

Levels of the HIV entry inhibitor maraviroc (Celsentri/Selzentry) in
vaginal and rectal tissues did not reach high enough levels with a single oral dose
to confer protection against HIV in a laboratory ...

Three antiretroviral drugs are associated with a slowly
increasing rate of chronic kidney disease over time, the Conference on Retroviruses and Opportunistic Infections (CROI 2015) in Seattle, USA,
heard today.
Although the risk ...

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.